The Role of Galectin-9 As Mediator of Atopic Dermatitis: Effect on Keratinocytes

Overview

Journal Cells

Publisher MDPI

Specialties Biochemistry
Biophysics
Cell Biology
Molecular Biology

Date 2021 Apr 30

PMID 33923930

Citations 2

Authors

Mab P Correa

Libnah L Areias

Rebeca D Correia-Silva

Solange C G P DAvila

Andreia M Leopoldino

Karin V Greco

Cristiane D Gil

Affiliations

Soon will be listed here.

Abstract

Galectin-9 (Gal-9) is a beta-galactoside-binding protein with a variety of biological functions related to immune response. However, in allergic diseases, its mechanism of action is not fully understood. This study evaluates the expression pattern of Gal-9 in patients with atopic dermatitis (AD), in ovalbumin (OVA)-induced experimental atopic dermatitis (AD) in mice, as well as its effect on human keratinocytes. The skin of OVA-immunized BALB/c mice was challenged with drops containing OVA on days 11, 14-18, and 21-24. HaCaT cells were cultured in the following experimental conditions: control (growth medium only) or stimulated with TNF-α/IFN-γ, or IL-4, or IL-17 with or without Gal-9 treatment. AD was characterized by increased levels of Gal-9 in mouse and human skin, especially in the epidermis, and with a marked influx of Gal-9 positive eosinophils and mast cells compared to the control group. Gal-9 showed an immunomodulatory effect on keratinocytes by decreasing the release of IL-6 by IL-4-stimulated keratinocytes or increasing the IL-6 and RANTES levels by IL-17- or TNF-α/IFN-γ-stimulated cells, respectively. Under IL-17, Gal-9 treatment also altered the proliferation rate of cells. Overall, increased levels of Gal-9 in AD skin contribute to the control of inflammatory response and the proliferative process of keratinocytes, suggesting this lectin as a relevant therapeutic target.

Citing Articles

The role of galectins in the regulation of autophagy and inflammasome in host immunity.

Lo T, Weng I, Chen H, Liu F Semin Immunopathol. 2024; 46(3-4):6.

PMID: 39042263 DOI: 10.1007/s00281-024-01018-5.

Design and Evaluation of Paeonol-Loaded Liposomes in Thermoreversible Gels for Atopic Dermatitis.

Wang Y, Yue Y, Jia R, Liu X, Cheng Z, Cheng Y Gels. 2023; 9(3).

PMID: 36975647 PMC: 10047988. DOI: 10.3390/gels9030198.

References

Liu F, Goodarzi H, Chen H . IgE, mast cells, and eosinophils in atopic dermatitis. Clin Rev Allergy Immunol. 2011; 41(3):298-310. DOI: 10.1007/s12016-011-8252-4. View

Kim H, Kim Y, Kang M, Seo J, Kim H, Jeong S . A novel mouse model of atopic dermatitis with epicutaneous allergen sensitization and the effect of Lactobacillus rhamnosus. Exp Dermatol. 2012; 21(9):672-5. DOI: 10.1111/j.1600-0625.2012.01539.x. View

Zhou S, Qi F, Gong Y, Zhang J, Zhu B . Biological Therapies for Atopic Dermatitis: A Systematic Review. Dermatology. 2021; 237(4):542-552. DOI: 10.1159/000514535. View

Farag A, Al-Sharaky D, Allam S, Khaled H . Role of Galectin-9 in Atopic Dermatitis - Is It Mediated Through E Selectin? A Clinical and Immunohistochemical Study. Clin Cosmet Investig Dermatol. 2020; 13:11-19. PMC: 6959497. DOI: 10.2147/CCID.S229393. View

Niki T, Tsutsui S, Hirose S, Aradono S, Sugimoto Y, Takeshita K . Galectin-9 is a high affinity IgE-binding lectin with anti-allergic effect by blocking IgE-antigen complex formation. J Biol Chem. 2009; 284(47):32344-52. PMC: 2781649. DOI: 10.1074/jbc.M109.035196. View

Brunner P, Guttman-Yassky E, Leung D . The immunology of atopic dermatitis and its reversibility with broad-spectrum and targeted therapies. J Allergy Clin Immunol. 2017; 139(4S):S65-S76. PMC: 5405702. DOI: 10.1016/j.jaci.2017.01.011. View

Katoh S, Shimizu H, Obase Y, Oomizu S, Niki T, Ikeda M . Preventive effect of galectin-9 on double-stranded RNA-induced airway hyperresponsiveness in an exacerbation model of mite antigen-induced asthma in mice. Exp Lung Res. 2013; 39(10):453-62. DOI: 10.3109/01902148.2013.850558. View

Fukuda K, Ohbayashi M, Morohoshi K, Zhang L, Liu F, Ono S . Critical role of IgE-dependent mast cell activation in a murine model of allergic conjunctivitis. J Allergy Clin Immunol. 2009; 124(4):827-33.e2. DOI: 10.1016/j.jaci.2009.06.012. View

Kim H, Kim J, Kang H, Choi J, Yang H, Lee P . 7,8,4'-Trihydroxyisoflavone attenuates DNCB-induced atopic dermatitis-like symptoms in NC/Nga mice. PLoS One. 2014; 9(8):e104938. PMC: 4149428. DOI: 10.1371/journal.pone.0104938. View

10.

Cedeno-Laurent F, Barthel S, Opperman M, Lee D, Clark R, Dimitroff C . Development of a nascent galectin-1 chimeric molecule for studying the role of leukocyte galectin-1 ligands and immune disease modulation. J Immunol. 2010; 185(8):4659-72. PMC: 2953643. DOI: 10.4049/jimmunol.1000715. View

11.

Matsuoka H, Maki N, Yoshida S, Arai M, Wang J, Oikawa Y . A mouse model of the atopic eczema/dermatitis syndrome by repeated application of a crude extract of house-dust mite Dermatophagoides farinae. Allergy. 2003; 58(2):139-45. DOI: 10.1034/j.1398-9995.2003.23790.x. View

12.

Kim H, Ju D, Kye Y, Ju Y, Kim C, Lee I . Galectin-9 Induced by Dietary Probiotic Mixture Regulates Immune Balance to Reduce Atopic Dermatitis Symptoms in Mice. Front Immunol. 2020; 10:3063. PMC: 6987441. DOI: 10.3389/fimmu.2019.03063. View

13.

Katoh S, Ishii N, Nobumoto A, Takeshita K, Dai S, Shinonaga R . Galectin-9 inhibits CD44-hyaluronan interaction and suppresses a murine model of allergic asthma. Am J Respir Crit Care Med. 2007; 176(1):27-35. DOI: 10.1164/rccm.200608-1243OC. View

14.

Grewe M, Czech W, Morita A, Werfel T, Klammer M, Kapp A . Human eosinophils produce biologically active IL-12: implications for control of T cell responses. J Immunol. 1998; 161(1):415-20. View

15.

Sato M, Nishi N, Shoji H, Seki M, Hashidate T, Hirabayashi J . Functional analysis of the carbohydrate recognition domains and a linker peptide of galectin-9 as to eosinophil chemoattractant activity. Glycobiology. 2002; 12(3):191-7. DOI: 10.1093/glycob/12.3.191. View

16.

Leung D, Guttman-Yassky E . Deciphering the complexities of atopic dermatitis: shifting paradigms in treatment approaches. J Allergy Clin Immunol. 2014; 134(4):769-79. PMC: 4186710. DOI: 10.1016/j.jaci.2014.08.008. View

17.

Chieosilapatham P, Kiatsurayanon C, Umehara Y, Trujillo-Paez J, Peng G, Yue H . Keratinocytes: innate immune cells in atopic dermatitis. Clin Exp Immunol. 2021; 204(3):296-309. PMC: 8119845. DOI: 10.1111/cei.13575. View

18.

Yamamoto H, Kashio Y, Shoji H, Shinonaga R, Yoshimura T, Nishi N . Involvement of galectin-9 in guinea pig allergic airway inflammation. Int Arch Allergy Immunol. 2007; 143 Suppl 1:95-105. DOI: 10.1159/000101414. View

19.

Saita N, Goto E, Yamamoto T, Cho I, Tsumori K, Kohrogi H . Association of galectin-9 with eosinophil apoptosis. Int Arch Allergy Immunol. 2002; 128(1):42-50. DOI: 10.1159/000058002. View

20.

Guttman-Yassky E, Bissonnette R, Ungar B, Suarez-Farinas M, Ardeleanu M, Esaki H . Dupilumab progressively improves systemic and cutaneous abnormalities in patients with atopic dermatitis. J Allergy Clin Immunol. 2018; 143(1):155-172. DOI: 10.1016/j.jaci.2018.08.022. View